-
1
-
2
-
1
-
2
Clearpol's Opinion of this Guidance as of 04/22/2013
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol's Summary of this Guidance

The California Department of Public Health (CDPH) has issued an All Facilities Letter addressing the nationwide shortage of Tuberculin Skin Test Antigens. The letter provides guidance for healthcare facilities, including nursing homes, to request program flexibility for using alternate testing methods. CDPH has developed proposed regulations allowing the use of any test for tuberculin infection recommended by the CDC and licensed by the FDA. These regulations are currently under review by the Office of Administrative Law. In the meantime, healthcare facilities can use the attached template letter to request program flexibility from District Offices, which will expedite the process. The CDC recommends substituting the Interferon Gamma Release Assay (IGRA) blood tests to identify tuberculosis during the shortage. Facilities should contact their local District Office for further questions.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions or summaries provided on our platform. Please use your own judgement.
You have 0 new tasks available
Below are AI generated tasks related to this document. Accept or deny a task.
Task | Deadline | Actions |
---|
No suggested tasks available at the moment!
AI generated tasks related to this document are shown here. Tasks may be coming soon or you may have accepted/denied all the available tasks for this document.
The document is ready to print
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
Copy Document Link
Please enter a Name.
Please enter a valid email address.
Please enter a first name.
Please enter a last name.
Please enter a valid email address.